Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | REGN6569 |
Trade Name | |
Synonyms | REGN-6569|REGN 6569 |
Drug Descriptions |
REGN6569 is a monoclonal antibody that binds to and activates the glucocorticoid-induced tumor necrosis factor receptor (GITR, TNFRSF18) expressed on immune cells, potentially leading to activation and proliferation of effector T cells and anti-tumor immune response (J Clin Oncol 42, 2024 (suppl 16; abstr 2650, NCI Drug Dictionary). |
DrugClasses | GITR Antibody 7 |
CAS Registry Number | NA |
NCIT ID | C178331 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cemiplimab + REGN6569 | Cemiplimab REGN6569 | 0 | 1 |
REGN6569 | REGN6569 | 0 | 0 |